Gilead Sciences Reports 2Q Profit Decline Due to Legal Settlement and Operating Costs
Introduction Gilead Sciences, a biopharmaceutical company based in Foster City, California, has reported a drop in second-quarter profit. This decline can be attributed to a settlement in HIV antitrust litigation…